Zobrazeno 1 - 10
of 308
pro vyhledávání: '"Anti-cancer treatment"'
Publikováno v:
Zhongguo aizheng zazhi, Vol 34, Iss 8, Pp 785-805 (2024)
Oxaliplatin serves as a basic therapeutic agent for various malignant tumors. Oxaliplatin-induced hypersensitivity reactions are potentially life-threatening, and frequently lead to treatment discontinuation. Alternative therapies may be less effecti
Externí odkaz:
https://doaj.org/article/9d8d278d7e0d44e081f87de9867dc3de
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 177, Iss , Pp 116962- (2024)
Metabolic disorders are considered the hallmarks of cancer and metabolic reprogramming is emerging as a new strategy for cancer treatment. Exogenous and endogenous stressors can induce cellular senescence; the interactions between cellular senescence
Externí odkaz:
https://doaj.org/article/b391e44f5197499ea64859816464ca5d
Publikováno v:
Indian Heart Journal, Vol 75, Iss 6, Pp 398-402 (2023)
Having established the significance of cardiovascular side-effects of anti-neoplastic drugs, present day cardio-oncology has forayed into newer territories buoyed by research into the multiple connections that exist between cardiovascular disease and
Externí odkaz:
https://doaj.org/article/fa6d2d53caf9425cb825589aa1b00f33
Publikováno v:
International Journal of Nanomedicine, Vol Volume 18, Pp 6037-6058 (2023)
Chonggao Wang,1,2 Yewei Zhang3 1Department of Thyroid Surgery, Nanjing Hospital of Chinese Medicine, Nanjing, 210001, People’s Republic of China; 2School of Medicine, Southeast University, Nanjing, 210001, People’s Republic of China; 3Hepatopancr
Externí odkaz:
https://doaj.org/article/50c68219a2e741e5a9851c29a0fe8664
Autor:
Meden F. Isaac-Lam
Publikováno v:
Pharmaceuticals, Vol 17, Iss 5, p 576 (2024)
Breast cancer (BC) is the most common type of cancer in women and the number of new cases in the US is still increasing each year. Triple-negative breast cancer (TNBC), which comprises 15–20% of all breast cancer, is a heterogeneous disease and is
Externí odkaz:
https://doaj.org/article/eef671044d0246d59ffec251ccfba8cb
Publikováno v:
Genome Medicine, Vol 14, Iss 1, Pp 1-16 (2022)
Abstract Cancer development is an evolutionary process. A key selection pressure is exerted by therapy, one of the few players in cancer evolution that can be controlled. As such, an understanding of how treatment acts to sculpt the tumour and its mi
Externí odkaz:
https://doaj.org/article/2b0afa506c4d46b3a376ebc5cbd3d3e4
Autor:
Safir Ullah Khan, Munir Ullah Khan, Muhammad Azhar Ud Din, Ibrar Muhammad Khan, Muhammad Imran Khan, Simona Bungau, Syed Shams ul Hassan
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
In the last ten years, it has become increasingly clear that tumor-infiltrating myeloid cells drive not just carcinogenesis via cancer-related inflammatory processes, but also tumor development, invasion, and metastasis. Tumor-associated macrophages
Externí odkaz:
https://doaj.org/article/bde790d00a24432ca49f1e96dcaf545b
Publikováno v:
BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background The need to mitigate the volume of unplanned emergency department (ED) presentations is a priority for health systems globally. Current evidence on the incidence and risk factors associated with unplanned ED presentations is uncle
Externí odkaz:
https://doaj.org/article/8ae23f764bd14efa88ea967aa40c70d8
Autor:
Jielin Wei, Mengjiao Wu, Jing Liu, Xu Wang, Pengfei Xia, Ling Peng, Yu Huang, Cuiwei Liu, Zihan Xia, Chuang Chen, Yanxia Zhao
Publikováno v:
Breast, Vol 59, Iss , Pp 102-109 (2021)
Background: The COVID-19 pandemic is a significant worldwide health crisis. Breast cancer patients with COVID-19 are fragile and require particular clinical care. This study aimed to identify the clinical characteristics of breast cancer patients wit
Externí odkaz:
https://doaj.org/article/f836c25dd86a4608a146166422694eae
Autor:
Marina Patysheva, Anastasia Frolova, Irina Larionova, Sergey Afanas'ev, Anna Tarasova, Nadezhda Cherdyntseva, Julia Kzhyshkowska
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Monocytes in peripheral blood circulation are the precursor of essential cells that control tumor progression, that include tumor-associated macrophages (TAMs), dendritic cells (DCs) and myeloid-derive suppressor cells (MDSC). Monocytes-derived cells
Externí odkaz:
https://doaj.org/article/e3e8117149f445f0b41f79b7c19235d2